Call Options

25 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.2 - $2.17 $170,400 - $308,140
142,000 Added 72.93%
336,700 $572,000
Q2 2024

Aug 15, 2024

BUY
$1.36 - $3.65 $83,776 - $224,840
61,600 Added 46.28%
194,700 $266,000
Q1 2024

May 07, 2024

SELL
$3.52 - $9.59 $898,656 - $2.45 Million
-255,300 Reduced 65.73%
133,100 $499,000
Q4 2023

Feb 14, 2024

BUY
$5.97 - $10.36 $630,432 - $1.09 Million
105,600 Added 37.34%
388,400 $3.81 Million
Q3 2023

Nov 14, 2023

BUY
$8.23 - $13.93 $260,068 - $440,188
31,600 Added 12.58%
282,800 $2.36 Million
Q2 2023

Aug 11, 2023

SELL
$9.97 - $14.05 $7.63 Million - $10.8 Million
-765,500 Reduced 75.29%
251,200 $3.34 Million
Q1 2023

May 16, 2023

BUY
$7.94 - $12.02 $6.37 Million - $9.64 Million
802,300 Added 374.21%
1,016,700 $11.8 Million
Q4 2022

Feb 14, 2023

SELL
$5.67 - $11.2 $1.34 Million - $2.65 Million
-237,000 Reduced 52.5%
214,400 $1.75 Million
Q3 2022

Nov 14, 2022

BUY
$3.93 - $8.57 $87,246 - $190,254
22,200 Added 5.17%
451,400 $2.62 Million
Q2 2022

Aug 15, 2022

BUY
$4.02 - $10.43 $971,231 - $2.52 Million
241,600 Added 128.78%
429,200 $1.9 Million
Q1 2022

May 16, 2022

BUY
$8.43 - $20.9 $766,287 - $1.9 Million
90,900 Added 94.0%
187,600 $1.71 Million
Q4 2021

Feb 14, 2022

SELL
$19.26 - $30.08 $198,378 - $309,824
-10,300 Reduced 9.63%
96,700 $1.98 Million
Q3 2021

Nov 15, 2021

SELL
$24.86 - $35.02 $628,958 - $886,006
-25,300 Reduced 19.12%
107,000 $2.73 Million
Q2 2021

Aug 11, 2021

SELL
$22.3 - $36.02 $4.92 Million - $7.95 Million
-220,800 Reduced 62.53%
132,300 $4.63 Million
Q1 2021

May 17, 2021

BUY
$26.38 - $51.15 $2.13 Million - $4.14 Million
80,900 Added 29.72%
353,100 $11.8 Million
Q4 2020

Feb 16, 2021

BUY
$10.5 - $28.5 $1.4 Million - $3.8 Million
133,400 Added 96.11%
272,200 $7.06 Million
Q3 2020

Nov 16, 2020

BUY
$3.61 - $9.87 $178,695 - $488,564
49,500 Added 55.43%
138,800 $1.37 Million
Q2 2020

Aug 14, 2020

BUY
$2.65 - $4.03 $57,240 - $87,048
21,600 Added 31.91%
89,300 $308,000
Q1 2020

May 15, 2020

BUY
$2.36 - $5.26 $44,132 - $98,362
18,700 Added 38.16%
67,700 $207,000
Q4 2019

Feb 14, 2020

SELL
$4.6 - $5.57 $126,959 - $153,732
-27,600 Reduced 36.03%
49,000 $252,000
Q2 2019

Aug 14, 2019

BUY
$5.92 - $7.41 $239,168 - $299,364
40,400 Added 111.6%
76,600 $463,000
Q1 2019

May 15, 2019

SELL
$6.8 - $7.4 $72,080 - $78,440
-10,600 Reduced 22.65%
36,200 $262,000
Q4 2018

Feb 14, 2019

BUY
$3.99 - $7.82 $98,952 - $193,936
24,800 Added 112.73%
46,800 $346,000
Q2 2018

Aug 14, 2018

BUY
$2.11 - $3.92 $7,174 - $13,328
3,400 Added 18.28%
22,000 $78,000
Q1 2018

May 15, 2018

BUY
$2.05 - $3.23 $38,130 - $60,078
18,600 New
18,600 $38,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.